Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES CorpNMTC · Entity 7808 | Chief Technology Officer | August 28, 2026 | August 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEUROONE MEDICAL TECHNOLOGIES Corp
Report date August 28, 2026 · Filed August 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.77 · Expires 2036-08-27 | Direct | 15,000 |
Reported balance
After 2026-08-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-28 · Grant · Acquired 15,000 · Balance 15,000 F1: 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 28, 2026 Filed Aug 28, 2026 20:57 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 15,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001772652-26-000006 · primary_doc.xml · derivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2036-08-27 F1 · derivative.exercise_date: 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments. Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 20:08 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 906 | $0.78 | $703.96 |
DisclosureSEC source: 0001772652-26-000005 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,141 Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 19:27 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 7,376 | $0.68 | $5,015.68 |
DisclosureSEC source: 0001772652-26-000004 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,047 Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:46 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 906 | $0.76 | $686.75 |
DisclosureSEC source: 0001772652-26-000001 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,423 Read SEC document |
| September 30, 2025 Filed Oct 1, 2025 18:20 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 906 | $0.89 | $805.07 |
DisclosureSEC source: 0001772652-25-000006 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,329 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 14:58 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 906 | $0.68 | $614.27 |
DisclosureSEC source: 0001540354-25-000007 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,235 Read SEC document |
| April 17, 2025 Filed Apr 21, 2025 21:02 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 200,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001772652-25-000004 · primary_doc.xml · derivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2035-04-16 F1 · derivative.exercise_date: 25% will vest on April 17, 2026, and the remaining 75% will vest in 12 equal quarterly installments. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:11 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 906 | $0.85 | $770.28 |
DisclosureSEC source: 0001772652-25-000003 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,141 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:47 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 7,376 | $1.16 | $8,556.16 |
DisclosureSEC source: 0001772652-25-000002 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,047 Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 18:48 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $1.15 | $289.80 |
DisclosureSEC source: 0001772652-25-000001 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,423 Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 20:41 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 1,158 | $0.83 | $956.51 |
DisclosureSEC source: 0001213900-25-000720 · ownership.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,675 Read SEC document |
| November 30, 2024 Filed Dec 3, 2024 22:04 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $0.62 | $157.02 |
DisclosureSEC source: 0001772652-24-000013 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,833 Read SEC document |
| October 31, 2024 Filed Nov 1, 2024 21:23 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $0.97 | $244.44 |
DisclosureSEC source: 0001772652-24-000012 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,085 Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 15:44 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 1,158 | $0.99 | $1,146.42 |
DisclosureSEC source: 0001772652-24-000011 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,337 Read SEC document |
| August 31, 2024 Filed Sep 4, 2024 15:43 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $0.80 | $200.69 |
DisclosureSEC source: 0001772652-24-000010 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,495 Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 18:38 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $0.75 | $189.00 |
DisclosureSEC source: 0001772652-24-000009 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,747 Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 15:21 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 1,158 | $0.80 | $926.40 |
DisclosureSEC source: 0001772652-24-000008 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,999 Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 15:48 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $0.93 | $234.33 |
DisclosureSEC source: 0001772652-24-000007 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,157 Read SEC document |
| April 30, 2024 Filed May 2, 2024 13:06 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $1.13 | $284.76 |
DisclosureSEC source: 0001772652-24-000006 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,409 Read SEC document |
| April 21, 2024 Filed Apr 23, 2024 14:21 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 7,250 | $1.15 | $8,337.50 |
DisclosureSEC source: 0001772652-24-000005 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,661 Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 15:52 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $1.20 | $302.40 |
DisclosureSEC source: 0001772652-24-000004 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,911 Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 19:10 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $1.21 | $304.92 |
DisclosureSEC source: 0001772652-24-000003 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,163 Read SEC document |
| February 18, 2024 Filed Feb 21, 2024 16:08 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantCommon Stock | 101,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001772652-24-000002 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,415 F1 · shares: Represents a grant of restricted stock units, which vest as to 25% of the shares on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 18:51 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $1.25 | $315.00 |
DisclosureSEC source: 0001772652-24-000001 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,672 Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 18:30 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $1.58 | $398.16 |
DisclosureSEC source: 0001213900-24-000532 · ownership.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,924 Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:32 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $1.45 | $365.40 |
DisclosureSEC source: 0001772652-23-000013 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,176 Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 23:03 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 81,067 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001772652-23-000012 · primary_doc.xml · derivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,067 Underlying: Common Stock · 81,067 shares Expires 2033-11-08 F1 · derivative.exercise_date: 25% will vest on November 9, 2024, and the remaining 75% will vest in 36 equal monthly installments on the last day of each month following November 9, 2024. Read SEC document |
| November 02, 2023 Filed Nov 3, 2023 20:07 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $1.61 | $405.72 |
DisclosureSEC source: 0001772652-23-000011 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,428 Read SEC document |
| October 31, 2023 Filed Nov 2, 2023 20:14 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $0.90 | $226.80 |
DisclosureSEC source: 0001772652-23-000010 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,680 Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 19:40 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $0.89 | $224.38 |
DisclosureSEC source: 0001772652-23-000009 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,932 Read SEC document |
| August 31, 2023 Filed Sep 5, 2023 15:48 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $0.85 | $214.33 |
DisclosureSEC source: 0001772652-23-000008 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,184 Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 20:00 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $1.02 | $257.04 |
DisclosureSEC source: 0001772652-23-000007 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,436 Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 18:08 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $1.20 | $302.40 |
DisclosureSEC source: 0001772652-23-000006 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,688 Read SEC document |
| May 31, 2023 Filed Jun 1, 2023 20:57 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $1.21 | $304.92 |
DisclosureSEC source: 0001772652-23-000005 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,940 Read SEC document |
| April 30, 2023 Filed May 2, 2023 19:48 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $1.54 | $388.08 |
DisclosureSEC source: 0001772652-23-000004 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,192 Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 19:27 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 50,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001772652-23-000003 · primary_doc.xml · derivative · entry 2 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-04-20 F2 · derivative.exercise_date: 25% will vest on April 21, 2024 and the remaining 75% will vest in 12 equal quarterly installments on the last day of each quarter beginning on June 30, 2024. Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 19:27 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001772652-23-000003 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,444 F1 · shares: Represents a grant of restricted stock units, which vest as to 50% of the shares on the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments on the last day of each quarter over the next 8 quarters, subject to continued service on such vesting date. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:31 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 252 | $1.61 | $405.72 |
DisclosureSEC source: 0001772652-23-000002 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,444 Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:44 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 6,054 | $1.47 | $8,899.38 |
DisclosureSEC source: 0001772652-23-000001 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,696 Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 23:17 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantCommon Stock | 41,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001772652-22-000001 · primary_doc.xml · nonDerivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,750 F1 · shares: Represents a grant of restricted stock units, which vest as to 50% of the shares on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments on the last day of each month over the next 24 months, subject to continued service on such vesting date. Read SEC document |
| January 27, 2021 Filed Jan 29, 2021 21:59 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 70,000 | $0.00 Strike: $1.99 | $0.00 |
DisclosureSEC source: 0001596771-21-000006 · primary_doc.xml · derivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2031-01-27 F1 · derivative.exercise_date: 25% will vest on January 27, 2022 and the remaining 75% will vest in 36 equal monthly installments on the last day of each month beginning on February 28, 2022. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:04 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 129,445 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001596771-19-000041 · primary_doc.xml · derivative · entry 1 Mertens Steve · CIK 0001772652 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,445 Underlying: Common Stock · 129,445 shares Expires 2029-05-13 F1 · derivative.exercise_date: The options were granted on May 13, 2019. 32,361 options immediately vested on the grant date, and the remaining options will vest in 36 equal monthly installments beginning on April 1, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.